333 related articles for article (PubMed ID: 11396261)
1. [From gene to disease; from homocysteine to hyperhomocysteinemia].
Boers GH
Ned Tijdschr Geneeskd; 2001 May; 145(20):956-8. PubMed ID: 11396261
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia, atherosclerosis and thrombosis.
Cattaneo M
Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase gene mutation and hyperhomocysteinemia as a risk factor for coronary heart disease in the Indian population.
Nair KG; Nair SR; Ashavaid TF; Dalal JJ; Eghlim FF
J Assoc Physicians India; 2002 May; 50 Suppl():9-15. PubMed ID: 12186157
[TBL] [Abstract][Full Text] [Related]
4. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
Boers GH
Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
[TBL] [Abstract][Full Text] [Related]
6. Are heterocygotes for classical homocystinuria at risk of vitamin B12 and folic acid deficiency?
Elsaid MF; Bener A; Lindner M; Alzyoud M; Shahbek N; Abdelrahman MO; Abdoh G; Bessisso MS; Zschocke J; Hoffmann GF
Mol Genet Metab; 2007; 92(1-2):100-3. PubMed ID: 17686644
[TBL] [Abstract][Full Text] [Related]
7. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
Yap S; Naughten ER; Wilcken B; Wilcken DE; Boers GH
Semin Thromb Hemost; 2000; 26(3):335-40. PubMed ID: 11011851
[TBL] [Abstract][Full Text] [Related]
8. Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans.
Heil SG; Lievers KJ; Boers GH; Verhoef P; den Heijer M; Trijbels FJ; Blom HJ
Mol Genet Metab; 2000 Nov; 71(3):511-9. PubMed ID: 11073719
[TBL] [Abstract][Full Text] [Related]
9. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease.
Malinowska A; Chmurzynska A
Nutr Res; 2009 Oct; 29(10):685-95. PubMed ID: 19917447
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
12. The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller AL
Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
[TBL] [Abstract][Full Text] [Related]
13. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway.
Alberto JM; Hamelet J; Noll C; Blaise S; Bronowicki JP; Guéant JL; Delabar JM; Janel N
Mol Genet Metab; 2007 Aug; 91(4):396-8. PubMed ID: 17562377
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
Boers GH
Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
[TBL] [Abstract][Full Text] [Related]
15. Genetic modulation of homocysteinemia.
Rozen R
Semin Thromb Hemost; 2000; 26(3):255-61. PubMed ID: 11011843
[TBL] [Abstract][Full Text] [Related]
16. Genetics of hyperhomocysteinaemia in cardiovascular disease.
Lievers KJ; Kluijtmans LA; Blom HJ
Ann Clin Biochem; 2003 Jan; 40(Pt 1):46-59. PubMed ID: 12542910
[TBL] [Abstract][Full Text] [Related]
17. [Deregulation of homocysteine metabolism and consequences for the vascular system].
Nicolas JP; Chango A
Bull Acad Natl Med; 1997 Feb; 181(2):313-29; discussion 330-1. PubMed ID: 9235230
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice.
Hamelet J; Demuth K; Paul JL; Delabar JM; Janel N
J Hepatol; 2007 Jan; 46(1):151-9. PubMed ID: 17030070
[TBL] [Abstract][Full Text] [Related]
19. Hyperkeratosis in cystathionine beta synthase-deficient mice: an animal model of hyperhomocysteinemia.
Robert K; Maurin N; Ledru A; Delabar J; Janel N
Anat Rec A Discov Mol Cell Evol Biol; 2004 Oct; 280(2):1072-6. PubMed ID: 15386278
[TBL] [Abstract][Full Text] [Related]
20. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels.
Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; van Oppenraay-Emmerzaal D; den Heijer M; Trijbels FJ; Blom HJ
Eur J Hum Genet; 2001 Aug; 9(8):583-9. PubMed ID: 11528503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
